Trial Profile
Atomoxetine effects in humans.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 14 Dec 2011
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacodynamics
- 10 Sep 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 10 Sep 2009 Actual patient number (10) added as reported by ClinicalTrials.gov.
- 10 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.